ArQule, Inc. (NASDAQ:ARQL)
ArQule, Inc. is a biotechnology company engaged in the research and development of next-generation, small-molecule cancer therapeutics. The Company’s targeted, broad-spectrum products and research programs are focused on key biological processes that are central to cancer. ArQule’s lead clinical-stage products have been generated from two scientific platforms: Cancer Survival Protein modulation and Activated Checkpoint Therapy. The Cancer Survival Protein modulation platform has generated a clinical-stage product that mediates its effects by inhibiting the activity of a molecule known as c-Met, which plays multiple roles in cancer cell growth, survival, invasion, angiogenesis and metastasis. The ACT platform is designed to kill cancer cells selectively while sparing normal cells through direct activation of DNA damage response/checkpoint pathways. The Company’s lead ACT program, based on the E2F-1 pathway, is partnered with Roche.
ArQule, Inc. (NASDAQ:ARQL)’s Financial Overview
ArQule, Inc. (NASDAQ) declined -3.85% yesterday to close its trading session at $3.25. The company has 1 year Price Target of $7. ArQule, Inc. has 52-Week high of $7.21 and 52-Week Low of $1.46. The stock touched its 52-Week High on 7.21 and 52-Week Low on 1.46. The stock traded with the volume of 481541 shares yesterday. The firm shows the market capitalization of $368.39 Million.
ArQule, Inc. (NASDAQ) reported its last quarterly earnings on 9/29/2018 where the firm reported its Actual EPS of $-0.05/share against the analyst consensus estimate of $-0.06/share. The difference between the actual and expected EPS is $0.01 a share with a surprise factor of 16.7%.
The firm is trading with SMA20 of 8.55 Percent, SMA50 of -5.94 Percent and SMA200 of -25.68 percent. ArQule, Inc. has P/S value of 16.16 while its P/B value stands at 4.01. Similarly, the company has Return on Assets of -23 percent, Return on Equity of -42.7 percent and Return on Investment of 0 Percent. The company shows Gross Margin and Operating Margin of 0 percent and -51 percent respectively.
The Stock currently has Analyst’ mean Recommendation of 0 where the scale is from 1 to 5, 1 means Strong Buy and 5 means Sell.
The 6 analysts offering 12-month price forecasts for ArQule Inc have a median target of 7.00, with a high estimate of 7.25 and a low estimate of 6.75. The median estimate represents a +115.38% increase from the last price of 3.25.
ArQule, Inc. is estimated to report earnings on 03/04/2019. The upcoming earnings date is derived from an algorithm based on a company’s historical reporting dates.Our vendor, Zacks Investment Research, might revise this date in the future, once the company announces the actual earnings date. According to Zacks Investment Research, based on 4 analysts’ forecasts, the consensus EPS forecast for the quarter is $-0.08. The reported EPS for the same quarter last year was $-0.09.
Del Frisco’s Restaurant Group, Inc. (NASDAQ:DFRG)
Del Frisco’s Restaurant Group, LLC develops, owns and operates three contemporary, complementary restaurant concepts: Del Frisco’s Double Eagle Steak House, Sullivan’s Steakhouse and Del Frisco’s Grille. The restaurants offer selections that include steaks, lobster tails, lamb chops and fresh seafood, as well as an extensive wine selection. Del Frisco’s Restaurant Group, LLC is headquartered in Wichita, Kansas.
Del Frisco’s Restaurant Group, Inc. (NASDAQ:DFRG)’s Financial Outlook
The 3 analysts offering 12-month price forecasts for Del Frisco’s Restaurant Group Inc have a median target of 8.00, with a high estimate of 10.00 and a low estimate of 8.00. The median estimate represents a -3.96% decrease from the last price of 8.33.
Our vendor, Zacks Investment Research, hasn’t provided us with the upcoming earnings report date.
According to Zacks Investment Research, Del Frisco’s Restaurant Group, Inc. has a Consensus Recommendation of 3. (The Scale is from 1-5 where 1 means Strong Buy and 5 means Strong Sell).
The Stock surged 2.33% and closed its last trading session at $8.33. The company has the market capitalization of $271.22 Million. The stock has 52-week high of $18.85 and 52-Week low of $5.86. The firm touched its 52-Week high on 18.85 and 52-Week low on 5.86. The company has volume of 412405 shares. The company has a total of 32.56 Million shares outstanding.
Del Frisco’s Restaurant Group, Inc. (NASDAQ) in the last quarter reported its actual EPS of $-0.07/share where the analyst estimated EPS was $-0.26/share. The difference between the actual and Estimated EPS is $0.19. This shows a surprise factor of 73.1 percent.
The company has YTD performance of 16.5 percent. Beta for Del Frisco’s Restaurant Group, Inc. stands at 0.85 while its ATR (average true range) is 0.48. The company has Weekly Volatility of 3.32%% and Monthly Volatility of 6.54%%.
Del Frisco’s Restaurant Group, Inc. has distance from 20-day Simple Moving Average (SMA20) of 17.49%, Distance from 50-Day Simple Moving Average of 20.03 percent and Distance from 200-Day Simple Moving Average of -20.68%.
The Company currently has ROA (Return on Assets) of 0 percent, Return on Equity (ROE) of 0 Percent and Return on Investment (ROI) of -6.7% with Gross margin of 71.5 percent and Operating & Profit margin of 0% and 0% respectively.